These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7981959)

  • 21. Is Insulin Resistance a Feature of or a Primary Risk Factor for Cardiovascular Disease?
    Laakso M
    Curr Diab Rep; 2015 Dec; 15(12):105. PubMed ID: 26458376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A common mutation of the insulin receptor substrate-1 gene is a risk factor for coronary artery disease.
    Baroni MG; D'Andrea MP; Montali A; Pannitteri G; Barillà F; Campagna F; Mazzei E; Lovari S; Seccareccia F; Campa PP; Ricci G; Pozzilli P; Urbinati G; Arca M
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2975-80. PubMed ID: 10591678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus.
    Juhan-Vague I; Alessi MC; Vague P
    Ann Med; 1996 Aug; 28(4):371-80. PubMed ID: 8862693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Major nutrition-related risk factors of ischemic heart disease: dyslipoproteinemia, obesity, hypertension, glucose intolerance].
    Pados G
    Orv Hetil; 1999 Jul; 140(28):1563-72. PubMed ID: 10443132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The insulin sensitivity concept].
    Scheen AJ
    Diabetes Metab; 2001 Apr; 27(2 Pt 2):193-200. PubMed ID: 11452210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin resistance implications for type II diabetes mellitus and coronary heart disease.
    Haffner SM; Miettinen H
    Am J Med; 1997 Aug; 103(2):152-62. PubMed ID: 9274899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players.
    Zimmet P; Boyko EJ; Collier GR; de Courten M
    Ann N Y Acad Sci; 1999 Nov; 892():25-44. PubMed ID: 10842650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetics of Insulin Resistance and the Metabolic Syndrome.
    Brown AE; Walker M
    Curr Cardiol Rep; 2016 Aug; 18(8):75. PubMed ID: 27312935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does insulin resistance unite the separate components of the insulin resistance syndrome? Evidence from the Miami Community Health Study.
    Donahue RP; Bean JA; Donahue RD; Goldberg RB; Prineas RJ
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2413-7. PubMed ID: 9409209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modern methods of correction of systemic inflammation and insulin resistance by patients with coronary heart disease and diabetes mellitus type 2].
    Rasin MS; Shaenko ZA
    Lik Sprava; 2014; (3-4):60-5. PubMed ID: 25286600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type II diabetes and syndrome X. Pathogenesis and glycemic management.
    Karam JH
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):329-50. PubMed ID: 1612069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fasting hyperinsulinaemia and 2-h glycaemia predict coronary heart disease in patients with type 2 diabetes.
    Faghihi-Kashani S; Bonnet F; Hafezi-Nejad N; Heidari B; Aghajani Nargesi A; Sheikhbahaei S; Ebadi M; Esteghamati A
    Diabetes Metab; 2016 Feb; 42(1):55-61. PubMed ID: 26531321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men.
    Kuusisto J; Lempiäinen P; Mykkänen L; Laakso M
    Diabetes Care; 2001 Sep; 24(9):1629-33. PubMed ID: 11522711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dyslipidemia of diabetes and insulin resistance].
    Halimi S
    Nephrologie; 2000; 21(7):345-6. PubMed ID: 11200607
    [No Abstract]   [Full Text] [Related]  

  • 36. [Abdominal obesity and coronary heart disease. Pathophysiology and clinical significance].
    Hauner H
    Herz; 1995 Feb; 20(1):47-55. PubMed ID: 7713476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease.
    Wannamethee SG; Lowe GD; Shaper AG; Rumley A; Lennon L; Whincup PH
    Diabetologia; 2004 Sep; 47(9):1557-65. PubMed ID: 15365613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects.
    Festa A; D'Agostino R; Rautaharju P; Mykkänen L; Haffner SM
    Am J Cardiol; 2000 Nov; 86(10):1117-22. PubMed ID: 11074210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome.
    Reusch JE
    Am J Cardiol; 2002 Sep; 90(5A):19G-26G. PubMed ID: 12231075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.